Michael DeBaun
Risk of death in sickle cell disease
Feb. 22, 2017—Two factors commonly used to evaluate patients with sickle cell disease are associated with each other and can predict increased mortality, Vanderbilt researchers have discovered.
Pediatrics awarded physician-scientist training support
Feb. 18, 2016—The National Institutes of Health (NIH) has awarded Vanderbilt’s Department of Pediatrics a K12 training grant to support early career faculty to become physician-scientists, the first time the department has received such an award.
Retreat highlights pediatrics research at Vanderbilt
Jun. 9, 2015—Every day, physicians at Monroe Carell Jr. Children’s Hospital at Vanderbilt are looking for new and effective ways to care for their patients. Often that mission is carried out through clinical, basic and translational research across the institution and disciplines.
DeBaun’s Levi Watkins Lecture highlights the power of purpose
Oct. 16, 2014—Throughout his career in medicine, Michael R. DeBaun, M.D., has found moments to fight the status quo.
Vanderbilt’s DeBaun to deliver annual Levi Watkins Jr. Lecture
Oct. 9, 2014—Michael R. DeBaun, M.D., J.C. Peterson Professor of Pediatrics and Medicine at Vanderbilt, will be the keynote speaker at the 13th Annual Levi Watkins Jr. Lecture.
Mark your calendar: Watkins lecture Oct. 14
Sep. 12, 2014—Hear Michael R. DeBaun,professor of pediatrics and medicine at Vanderbilt School of Medicine.
Transfusions ease strokes for children with sickle cell
Aug. 21, 2014—Vanderbilt-led research found regular blood transfusion therapy significantly reduces the recurrence of strokes in children with sickle cell anemia who have previously had "silent" strokes.
Levi Watkins Jr. Lecture to feature DeBaun
Aug. 15, 2014—The Levi Watkins Jr. Lecture will be held Oct. 14, featuring keynote speaker Michael R. DeBaun.
DeBaun’s sickle cell disease research honored
Aug. 14, 2014—Michael R. DeBaun, M.D., MPH, has been recognized by the American Society of Hematology (ASH) for his significant contributions and research advances in the area of sickle cell disease.
Doris Duke awards enhance clinical research training
Jul. 31, 2014—Vanderbilt University’s Cyndya Shibao, M.D., MSCI, has received a Clinical Scientist Development Award from the Doris Duke Charitable Foundation.
Project targets sickle cell disease in Nigeria
Oct. 25, 2012—Researchers from the Monroe Carell Jr. Children’s Hospital at Vanderbilt and Aminu Kano Teaching Hospital in Kano, Nigeria, will work on a collaborative project to study a sickle cell disease treatment for children in Nigeria.
Vanderbilt sets record for number of new AAAS fellows
Dec. 14, 2011—Fourteen Vanderbilt researchers have been elected fellows of the American Association for the Advancement of Science (AAAS).